Vivus Inc. had signed a deal with Auxilium Pharmacauticals Inc to market its Stendra drug in the US market, said a Reuters report.
Vivus Inc
Breaking News
Vivus Inc. announced a new chief executive officer in the person of former Johnson & Johnson executive Seth H. Z. Fischer after Tony Zook resigned due to health issues.
Vivus wanted to reach a settlement with the biggest investors for board control.
On Wednesday, QVT Financial LP said that it would support the slate of activist investor First Manhattan Co as it proposed to change the board of directors at Vivus Inc.
Vivus Inc signed an impotence drug deal with Italy's Menarini Group for Eur95 million.
On Friday, Vivus Inc said that three of the nine people were recommended to the company’s board of directors by First Manhattan Co’s proxy advisory firm, ISS.
Subscribe to VCpost newsletter
Most Popular
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- Walmart Founder's Son Rob Walton to Step Down From Board
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- 3.6 Million Medicare Beneficiaries Could Now Get Wegovy Coverage; Here's How!
